TABLE 2.
Treatment results shown by subgroup in the botulinum toxin A therapy group (N=26)
SUBGROUP | SCORAD BEFORE (MEAN±SD) | SCORAD AFTER (MEAN±SD) | P-VALUE (AFTER VS. BEFORE) |
---|---|---|---|
All patients | 50±21 | 11±10 | <0.001 |
Sex | |||
Males | 52±21 | 14±12 | <0.001 |
Females | 50±21 | 9±6 | <0.001 |
Age | |||
<17 years | 47±19 | 10±7 | <0.001 |
≥17 years | 54±23 | 12±12 | <0.001 |
Duration | |||
<7 years | 55±21 | 11±8 | <0.001 |
≥7 years | 47±20 | 11±11 | <0.001 |
Onset | |||
<1.5 years | 53±19 | 14±11 | <0.001 |
≥1.5 years | 48±22 | 8±7 | <0.001 |
Baseline disease severity | |||
Mild (SCORAD<25 points) | 20±4 | 7±5 | 0.004 |
Moderate (SCORAD 25–50 points) | 38±8 | 19±6 | <0.001 |
Severe (SCORAD>50 points) | 69±11 | 14±12 | <0.001 |